Table 1.
Clinical data of the ovarian endometrioid carcinoma patients included in the study
| No of patients-ovarian endometrioid carcinoma n=20 (%) | ||
|---|---|---|
| Age | Median | 59.4 |
| range | 44-78 | |
| Differentiation grade | G1 | 1 (5%) |
| G2 | 6 (30%) | |
| G3 | 6 (30%) | |
| Unavailable | 3 (15%) | |
| Tumor stage | T1 | 7 (35%) |
| T2 | 3 (15%) | |
| T3 | 7 (35%) | |
| NA | 3 (15%) | |
| Lymph nodes | N0 | 3 (15%) |
| N1 | 1 (5%) | |
| NX | 13 (65%) | |
| Unavailable | 3 (15%) | |
| Metastasis | 13 (65%) | |
| Deceased | 8 (40%) | |
| Treatment | Paclitaxel + carboplatin | 13 (65%) |
| Doxorubicina + cisplatin | 1 (5%) | |
| Carboplatin | 1 (5%) | |
| unavailable | 5 (25%) |